Analysts split on J&J's Guidant buyout
7th Nov 2005, 23:58 GMT
Market analysts were split Monday on whether Johnson & Johnson can back out of its pending $25 billion deal to buy medical-device maker Guidant. Guidant ...
Analysts split on J&J's Guidant buyout related news:
- Postmasters' buyout plan could split Royal Mail — Times Online - Business and Markets News
- FTC Sets Guidelines for J&J's Guidant Buy — E-Commerce Times
- Guidant Sues Johnson to Force Buyout — NYT > Business
- Guidant Sues J& J to Force Completion of Buyout — washingtonpost.com - Business
- Guidant Sues J&J to Force Completion of Buyout, Posts Lower Earnings — KeralaNext: International
- Guidant Sues Johnson to Force Completion of $25.4 Billion Buyout — NYT > Home Page
- J&J rethinking Guidant buyout — United Press International - Health Business
- Analysts split over year-end stock rally — Business Times Online - Top Stories
- Guidant sues J&J to force completion of buyout — MSNBC.com: Business
- Guidant Says It Has Sued J&J to Force Completion of Buyout — KeralaNext: US
Latest news from United Press International - Health Business:
- AmerisourceBergen tests Rx tracking plan
- Lilly: Arxxant cuts sight loss in diabetes
- Merck: Arcoxia heart risk same as Voltaren
- Corcept tests psych. major depression Rx
- Neurogen's obesity drug in phase 1 trial
- Analysis: Insurance horizons expanding
- Dendreon seeks OK for Provenge
- Robots caring for stroke patients
- Diabetes drug stalls heart disease
- Diabetes drug also helps arteries